Cargando…
Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study
BACKGROUND: Subcutaneous (SC) versus intravenous (IV) administration is advantageous in terms of patient convenience and hospital efficiency. This study aimed to compare the effect of optimizing the processes involved in SC versus IV administration of rituximab and trastuzumab on hospital capacity a...
Autores principales: | Abad-Sazatornil, María Reyes, Arenaza, Ainhoa, Bayo, Juan, García Mata, Jesus, Guinea De Castro, José María, León, Josefa, Letellez, Javier, Reguero, Virginia, Martínez Chamorro, Carmen, Salar, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034176/ https://www.ncbi.nlm.nih.gov/pubmed/33832464 http://dx.doi.org/10.1186/s12913-021-06277-8 |
Ejemplares similares
-
Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
por: Waller, Cornelius F., et al.
Publicado: (2021) -
Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
por: Shpilberg, O, et al.
Publicado: (2013) -
Excelencia gerencial
por: Valdes Ramírez, María Beatriz
Publicado: (1994) -
Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
por: Pimentel, Franklin Fernandes, et al.
Publicado: (2018) -
SUMAMOS EXCELENCIA(®) Project: Results of the Implementation of Best Practice in a Spanish National Health System (NHS)
por: Martínez-Gimeno, María-Lara, et al.
Publicado: (2021)